GMP: FDA requires Registration of Manufacturing Facilities until December 2, 2012

In a Federal Register Notice dated October 2, 2012 the FDA is notifying companies who manufacture Generic Drug Products and Active Pharmaceutical Ingredients as well as certain other sites and organisations that support the manufacture or approval of these products to identify themselves with FDA.

kapitał ludzki

fundusz społeczny

Narodowe Centrum Badań i Rozwoju

innowacyjna gospodarka

rozwój regionalny